PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES

ABSTRACT: Capecitabine, oxaliplatin, irinotecan and bevacizumab as perioperative strategy of borderline and/or high risk resectable colorectal cancer liver metastases

DISEASE(S): Pazienti Affetti Da Metastasi Epatiche Di Carcionoma Colorettale, Operabili Ad Alto Rischio O Operabili "borderline",Neoplasm Metastasis,Colorectal Cancer,Colorectal Neoplasms,Liver Neoplasms,Colorectal Cancer Liver Metastases

PROVIDER: 2162638 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR